Correlation Between JPMorgan Chase and Seelos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and Seelos Therapeutics, you can compare the effects of market volatilities on JPMorgan Chase and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Seelos Therapeutics.

Diversification Opportunities for JPMorgan Chase and Seelos Therapeutics

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between JPMorgan and Seelos is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Seelos Therapeutics go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Seelos Therapeutics

Considering the 90-day investment horizon JPMorgan Chase Co is expected to generate 0.15 times more return on investment than Seelos Therapeutics. However, JPMorgan Chase Co is 6.87 times less risky than Seelos Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.22 per unit of risk. If you would invest  18,028  in JPMorgan Chase Co on August 25, 2024 and sell it today you would earn a total of  6,827  from holding JPMorgan Chase Co or generate 37.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy97.89%
ValuesDaily Returns

JPMorgan Chase Co  vs.  Seelos Therapeutics

 Performance 
       Timeline  
JPMorgan Chase 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.
Seelos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

JPMorgan Chase and Seelos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JPMorgan Chase and Seelos Therapeutics

The main advantage of trading using opposite JPMorgan Chase and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.
The idea behind JPMorgan Chase Co and Seelos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk